Solazyme General Counsel Sells $64,380 in Stock (SZYM)
Solazyme (NASDAQ:SZYM) General Counsel Paul Quinlan unloaded 6,000 shares of Solazyme stock on the open market in a transaction dated Thursday, September 19th. The stock was sold at an average price of $10.73, for a total transaction of $64,380.00. Following the transaction, the general counsel now directly owns 89,000 shares of the company’s stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
SZYM has been the subject of a number of recent research reports. Analysts at Robert W. Baird raised their price target on shares of Solazyme (NASDAQ:SZYM) from $12.00 to $16.00 in a research note to investors on Thursday, August 8th. They now have an “outperform” rating on the stock. Separately, analysts at Piper Jaffray Cos. reiterated an “underweight” rating on shares of Solazyme (NASDAQ:SZYM) in a research note to investors on Monday, June 24th. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme (NASDAQ:SZYM) in a research note to investors on Monday, June 24th.
One investment analyst has rated the stock with a sell rating and seven have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $13.38.
Shares of Solazyme (NASDAQ:SZYM) traded up 1.04% during mid-day trading on Thursday, hitting $10.71. The stock had a trading volume of 549,460 shares. Solazyme has a 52-week low of $6.45 and a 52-week high of $13.09. The stock’s 50-day moving average is $11.42 and its 200-day moving average is $10.39. The company’s market cap is $667.3 million.
Solazyme (NASDAQ:SZYM) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.40) by $0.12. The company had revenue of $11.20 million for the quarter, compared to the consensus estimate of $10.66 million. During the same quarter in the prior year, the company posted ($0.27) earnings per share. The company’s quarterly revenue was down 17.0% on a year-over-year basis. On average, analysts predict that Solazyme will post $-1.59 earnings per share for the current fiscal year.
Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.